| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.972 | 0 | 0.972 | Adenosine deaminase inhibitor | 0.967 0 DBMET00677 | ||
| 0.938 | 0.001 | 0.994 | DNA synthesis inhibitor | 0.994 0 DBMET00677 | DBMET00677 | |
| 0.922 | 0.001 | 0.922 | Adenosine A1 receptor antagonist | 0.427 0.004 DBMET00677 | ||
| 0.909 | 0.001 | 0.993 | RNA-directed DNA polymerase inhibitor | 0.993 0 DBMET00677 | DBMET00677 | |
| 0.835 | 0.001 | 0.835 | Adenosine A1 receptor agonist | 0.575 0.002 DBMET00677 | ||
| 0.832 | 0.001 | 0.832 | DNA methylase inhibitor | 0.773 0.002 DBMET00677 | ||
| 0.817 | 0.004 | 0.817 | Immunomodulator | 0.793 0.005 DBMET00677 | ||
| 0.814 | 0.001 | 0.814 | Adenosine A2a receptor antagonist | 0.286 0.006 DBMET00677 | ||
| 0.792 | 0.002 | 0.792 | Adenosine A2 receptor antagonist | 0.239 0.008 DBMET00677 | ||
| 0.786 | 0.001 | 0.895 | NADH dehydrogenase inhibitor | 0.895 0 DBMET00677 | DBMET00677 | |
| 0.766 | 0.002 | 0.766 | DNA methyltransferase I inhibitor | 0.27 0.039 DBMET00677 | ||
| 0.765 | 0.001 | 0.955 | Adenylate cyclase inhibitor | 0.955 0 DBMET00677 | DBMET00677 | |
| 0.754 | 0.001 | 0.754 | DNA repair enzyme inhibitor | 0.581 0.002 DBMET00677 | ||
| 0.738 | 0.001 | 0.738 | Adenosine A3 receptor antagonist | 0.448 0.003 DBMET00677 | ||
| 0.721 | 0.003 | 0.721 | Cyclic AMP phosphodiesterase inhibitor | 0.349 0.026 DBMET00677 | ||
| 0.677 | 0.002 | 0.929 | Antimetabolite | 0.929 0.001 DBMET00677 | DBMET00677 | |
| 0.618 | 0.001 | 0.618 | Adenosine A2b receptor agonist | 0.137 0.002 DBMET00677 | ||
| 0.617 | 0.002 | 0.693 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.693 0.001 DBMET00677 | DBMET00677 | |
| 0.617 | 0.008 | 0.617 | DNA damaging | 0.446 0.02 DBMET00677 | ||
| 0.584 | 0.001 | 0.844 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.844 0 DBMET00677 | DBMET00677 | |
| 0.574 | 0.001 | 0.574 | Adenosine A3 receptor agonist | 0.276 0.002 DBMET00677 | ||
| 0.568 | 0.002 | 0.787 | Carbamoyl phosphate synthetase inhibitor | 0.787 0 DBMET00677 | DBMET00677 | |
| 0.531 | 0.001 | 0.895 | Adenosine kinase inhibitor | 0.895 0 DBMET00677 | DBMET00677 | |
| 0.549 | 0.023 | 0.626 | Immunostimulant | 0.626 0.014 DBMET00677 | DBMET00677 | |
| 0.528 | 0.002 | 0.666 | UDP-glucose 4-epimerase inhibitor | 0.666 0 DBMET00677 | DBMET00677 | |
| 0.501 | 0.004 | 0.72 | DNA polymerase I inhibitor | 0.72 0.001 DBMET00677 | DBMET00677 | |
| 0.494 | 0.002 | 0.904 | Argininosuccinate synthase inhibitor | 0.904 0 DBMET00677 | DBMET00677 | |
| 0.487 | 0.002 | 0.972 | Purinergic P2Y antagonist | 0.972 0 DBMET00677 | DBMET00677 | |
| 0.511 | 0.026 | 0.683 | Vasodilator, peripheral | 0.683 0.007 DBMET00677 | DBMET00677 | |
| 0.484 | 0.002 | 0.823 | Phosphofructokinase-1 inhibitor | 0.823 0.001 DBMET00677 | DBMET00677 | |
| 0.478 | 0.014 | 0.478 | Anticonvulsant | |||
| 0.504 | 0.044 | 0.504 | Transcription factor NF kappa B inhibitor | |||
| 0.478 | 0.039 | 0.5 | Immunosuppressant | 0.5 0.033 DBMET00677 | DBMET00677 | |
| 0.439 | 0.002 | 0.622 | Adenylate kinase inhibitor | 0.622 0 DBMET00677 | DBMET00677 | |
| 0.431 | 0.002 | 0.896 | Ribonucleotide reductase inhibitor | 0.896 0.001 DBMET00677 | DBMET00677 | |
| 0.449 | 0.023 | 0.509 | Vasodilator, coronary | 0.509 0.014 DBMET00677 | DBMET00677 | |
| 0.473 | 0.049 | 0.473 | Antibacterial | 0.368 0.092 DBMET00677 | ||
| 0.494 | 0.076 | 0.494 | Apoptosis agonist | 0.398 0.114 DBMET00677 | ||
| 0.443 | 0.031 | 0.443 | Caspase 3 stimulant | 0.24 0.122 DBMET00677 | ||
| 0.434 | 0.03 | 0.434 | Apoptosis antagonist | 0.268 0.11 DBMET00677 | ||
| 0.406 | 0.004 | 0.656 | Aminoacyl-tRNA synthetase inhibitor | 0.656 0.002 DBMET00677 | DBMET00677 | |
| 0.4 | 0.005 | 0.795 | Aldehyde dehydrogenase inhibitor | 0.795 0.002 DBMET00677 | DBMET00677 | |
| 0.395 | 0.002 | 0.548 | Phosphoglycerate kinase inhibitor | 0.548 0 DBMET00677 | DBMET00677 | |
| 0.389 | 0.001 | 0.389 | Adenosine A2 receptor agonist | 0.116 0.002 DBMET00677 | ||
| 0.38 | 0.004 | 0.861 | Glutamate dehydrogenase inhibitor | 0.861 0.001 DBMET00677 | DBMET00677 | |
| 0.368 | 0.003 | 0.502 | Ribonucleoside-diphosphate reductase inhibitor | 0.502 0.002 DBMET00677 | DBMET00677 | |
| 0.36 | 0.013 | 0.671 | Cytidine deaminase inhibitor | 0.671 0.003 DBMET00677 | DBMET00677 | |
| 0.369 | 0.028 | 0.369 | Angiogenesis stimulant | 0.259 0.066 DBMET00677 | ||
| 0.344 | 0.013 | 0.344 | Peptidyltransferase inhibitor | 0.267 0.04 DBMET00677 | ||
| 0.316 | 0.004 | 0.316 | CF transmembrane conductance regulator agonist | |||
| 0.308 | 0.003 | 0.558 | Biliverdin reductase inhibitor | 0.558 0.001 DBMET00677 | DBMET00677 | |
| 0.294 | 0.002 | 0.842 | Thymidine kinase inhibitor | 0.842 0.001 DBMET00677 | DBMET00677 | |
| 0.272 | 0.001 | 0.272 | Adenosine A2a receptor agonist | 0.059 0.002 DBMET00677 | ||
| 0.312 | 0.042 | 0.312 | Interleukin agonist | |||
| 0.317 | 0.047 | 0.317 | Tumour necrosis factor alpha release inhibitor | |||
| 0.27 | 0.002 | 0.358 | Acyl-CoA dehydrogenase inhibitor | 0.358 0.001 DBMET00677 | DBMET00677 | |
| 0.284 | 0.017 | 0.284 | Interleukin 6 antagonist | 0.173 0.061 DBMET00677 | ||
| 0.254 | 0.001 | 0.591 | Purinergic P2X agonist | 0.591 0.001 DBMET00677 | DBMET00677 | |
| 0.255 | 0.002 | 0.574 | Purinergic P2X1 antagonist | 0.574 0 DBMET00677 | DBMET00677 | |
| 0.238 | 0.005 | 0.238 | Interferon agonist | 0.083 0.047 DBMET00677 | ||
| 0.23 | 0.002 | 0.23 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.099 0.003 DBMET00677 | ||
| 0.282 | 0.054 | 0.375 | Vasodilator | 0.375 0.028 DBMET00677 | DBMET00677 | |
| 0.212 | 0.003 | 0.858 | Fumarate hydratase inhibitor | 0.858 0.001 DBMET00677 | DBMET00677 | |
| 0.207 | 0 | 0.532 | Purinergic P2Y1 agonist | 0.532 0 DBMET00677 | DBMET00677 | |
| 0.205 | 0.005 | 0.205 | Adenosine A2b receptor antagonist | |||
| 0.255 | 0.07 | 0.388 | Platelet antagonist | 0.388 0.03 DBMET00677 | DBMET00677 | |
| 0.21 | 0.03 | 0.538 | Hexokinase inhibitor | 0.538 0.003 DBMET00677 | DBMET00677 | |
| 0.204 | 0.025 | 0.217 | Alkylator | 0.217 0.022 DBMET00677 | DBMET00677 | |
| 0.181 | 0.008 | 0.779 | Ornithine carbamoyltransferase inhibitor | 0.779 0.001 DBMET00677 | DBMET00677 | |
| 0.176 | 0.004 | 0.176 | Interferon inducer | |||
| 0.185 | 0.022 | 0.185 | Adenylate cyclase stimulant | 0.144 0.073 DBMET00677 | ||
| 0.316 | 0.154 | 0.797 | DNA directed DNA polymerase inhibitor | 0.797 0.02 DBMET00677 | DBMET00677 | |
| 0.172 | 0.016 | 0.653 | Heat shock protein 70 antagonist | 0.653 0.002 DBMET00677 | DBMET00677 | |
| 0.168 | 0.016 | 0.372 | Alcohol dehydrogenase inhibitor | 0.372 0.004 DBMET00677 | DBMET00677 | |
| 0.211 | 0.066 | 0.211 | Platelet adhesion inhibitor | 0.183 0.081 DBMET00677 | ||
| 0.147 | 0.002 | 0.299 | Purinergic P2Y1 antagonist | 0.299 0.001 DBMET00677 | DBMET00677 | |
| 0.163 | 0.02 | 0.465 | DNA directed RNA polymerase inhibitor | 0.465 0.004 DBMET00677 | DBMET00677 | |
| 0.145 | 0.002 | 0.145 | Thymidine phosphorylase inhibitor | 0.057 0.004 DBMET00677 | ||
| 0.252 | 0.116 | 0.252 | Interleukin 2 agonist | |||
| 0.144 | 0.011 | 0.144 | Cyclin E inhibitor | |||
| 0.141 | 0.01 | 0.141 | Cyclin E1 inhibitor | |||
| 0.13 | 0.002 | 0.13 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.042 0.005 DBMET00677 | ||
| 0.137 | 0.012 | 0.476 | Purinergic P2 antagonist | 0.476 0.004 DBMET00677 | DBMET00677 | |
| 0.139 | 0.014 | 0.296 | Purinergic P2X2 antagonist | 0.296 0.002 DBMET00677 | DBMET00677 | |
| 0.119 | 0.006 | 0.119 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.24 | 0.133 | 0.24 | Cholesterol antagonist | |||
| 0.109 | 0.007 | 0.109 | Nicotinic acid receptor 1 agonist | |||
| 0.163 | 0.061 | 0.163 | NOS3 expression enhancer | |||
| 0.163 | 0.062 | 0.255 | Insulin secretagoues | 0.255 0.019 DBMET00677 | DBMET00677 | |
| 0.144 | 0.043 | 0.144 | Topoisomerase I inhibitor | |||
| 0.102 | 0.001 | 0.102 | Isoleucine-tRNA ligase inhibitor | 0.032 0.005 DBMET00677 | ||
| 0.305 | 0.211 | 0.305 | Antiinflammatory | |||
| 0.094 | 0.003 | 0.188 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.188 0.001 DBMET00677 | DBMET00677 | |
| 0.12 | 0.031 | 0.12 | Thioredoxin inhibitor | |||
| 0.154 | 0.066 | 0.154 | Protein kinase stimulant | |||
| 0.093 | 0.005 | 0.445 | Purinergic P2T antagonist | 0.445 0.003 DBMET00677 | DBMET00677 | |
| 0.09 | 0.006 | 0.114 | AICAR transformylase inhibitor | 0.114 0.004 DBMET00677 | DBMET00677 | |
| 0.095 | 0.012 | 0.095 | Phosphodiesterase II inhibitor | 0.067 0.025 DBMET00677 | ||
| 0.146 | 0.066 | 0.146 | MAP3K9 inhibitor | |||
| 0.163 | 0.083 | 0.238 | Phospholipase C inhibitor | 0.238 0.027 DBMET00677 | DBMET00677 | |
| 0.077 | 0.002 | 0.077 | Purinergic P2Y15 antagonist | 0.039 0.007 DBMET00677 | ||
| 0.108 | 0.033 | 0.149 | Transcription factor NF kappa B stimulant | 0.149 0.016 DBMET00677 | DBMET00677 | |
| 0.086 | 0.012 | 0.086 | Phosphodiesterase 2A inhibitor | 0.06 0.024 DBMET00677 | ||
| 0.098 | 0.026 | 0.098 | T cell inhibitor | |||
| 0.116 | 0.044 | 0.116 | Protein kinase C mu inhibitor | |||
| 0.073 | 0.004 | 0.095 | Guanylate cyclase inhibitor | 0.095 0.001 DBMET00677 | DBMET00677 | |
| 0.165 | 0.098 | 0.165 | MAP kinase kinase 5 inhibitor | |||
| 0.066 | 0.005 | 0.364 | Purinergic P2Y12 antagonist | 0.364 0.003 DBMET00677 | DBMET00677 | |
| 0.101 | 0.045 | 0.101 | Histamine N-methyltransferase inhibitor | |||
| 0.057 | 0.002 | 0.057 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.078 | 0.023 | 0.078 | Transcription factor AP-1 inhibitor | |||
| 0.076 | 0.021 | 0.076 | Protein 50S ribosomal subunit inhibitor | 0.064 0.028 DBMET00677 | ||
| 0.055 | 0.003 | 0.543 | Purinergic receptor agonist | 0.543 0.001 DBMET00677 | DBMET00677 | |
| 0.055 | 0.003 | 0.543 | Purinergic P2 agonist | 0.543 0.001 DBMET00677 | DBMET00677 | |
| 0.065 | 0.014 | 0.073 | Thymidylate synthase inhibitor | 0.073 0.01 DBMET00677 | DBMET00677 | |
| 0.137 | 0.088 | 0.235 | Acetylcholine M1 receptor antagonist | 0.235 0.029 DBMET00677 | DBMET00677 | |
| 0.204 | 0.155 | 0.204 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.123 | 0.075 | 0.123 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.057 | 0.01 | 0.057 | Antibiotic Aminoglycoside-like | 0.043 0.019 DBMET00677 | ||
| 0.079 | 0.032 | 0.079 | Protein kinase C beta inhibitor | |||
| 0.046 | 0.001 | 0.514 | Purinergic P2Y2 agonist | 0.514 0 DBMET00677 | DBMET00677 | |
| 0.044 | 0.003 | 0.48 | Purinergic P2Y agonist | 0.48 0.001 DBMET00677 | DBMET00677 | |
| 0.05 | 0.01 | 0.202 | Purinergic P2Y2 antagonist | 0.202 0.002 DBMET00677 | DBMET00677 | |
| 0.045 | 0.005 | 0.137 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.137 0.002 DBMET00677 | DBMET00677 | |
| 0.078 | 0.038 | 0.078 | Phosphodiesterase VIII inhibitor | |||
| 0.208 | 0.168 | 0.263 | Antithrombotic | 0.263 0.116 DBMET00677 | DBMET00677 | |
| 0.162 | 0.128 | 0.162 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.035 | 0.002 | 0.059 | Methylmalonyl-CoA mutase inhibitor | 0.059 0 DBMET00677 | DBMET00677 | |
| 0.059 | 0.025 | 0.246 | Phosphorylase inhibitor | 0.246 0.004 DBMET00677 | DBMET00677 | |
| 0.154 | 0.127 | 0.154 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.027 | 0.004 | 0.027 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 DBMET00677 | ||
| 0.034 | 0.015 | 0.034 | Uridine phosphorylase inhibitor | |||
| 0.087 | 0.069 | 0.087 | Uric acid excretion stimulant | |||
| 0.093 | 0.077 | 0.266 | Expectorant | 0.266 0.011 DBMET00677 | DBMET00677 | |
| 0.076 | 0.06 | 0.076 | Antineoplastic antibiotic | |||
| 0.015 | 0.004 | 0.024 | Purine nucleoside phosphorylase inhibitor | 0.024 0.003 DBMET00677 | DBMET00677 | |
| 0.071 | 0.06 | 0.225 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.225 0.007 DBMET00677 | DBMET00677 | |
| 0.183 | 0.174 | 0.183 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.035 | 0.027 | 0.175 | Inosine monophosphate dehydrogenase inhibitor | 0.175 0.003 DBMET00677 | DBMET00677 | |
| 0.059 | 0.055 | 0.059 | Prolactin release inhibitor | |||
| 0.048 | 0.047 | 0.048 | Protein kinase C eta inhibitor | |||
| 0.089 | 0.09 | 0.106 | Folate antagonist | 0.106 0.055 DBMET00677 | DBMET00677 | |
| 0.002 | 0.003 | 0.014 | Purinergic P2Y6 agonist | 0.014 0.001 DBMET00677 | DBMET00677 | |
| 0.002 | 0.007 | 0.058 | Purinergic P2Y4 agonist | 0.058 0.001 DBMET00677 | DBMET00677 | |
| 0.013 | 0.026 | 0.106 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.106 0.003 DBMET00677 | DBMET00677 | |
| 0.053 | 0.067 | 0.335 | HIV-1 reverse transcriptase inhibitor | 0.335 0.005 DBMET00677 | DBMET00677 | |
| 0.073 | 0.097 | 0.195 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.195 0.016 DBMET00677 | DBMET00677 | |
| 0.032 | 0.083 | 0.371 | Purinergic P2X4 antagonist | 0.371 0.002 DBMET00677 | DBMET00677 | |
| 0.014 | 0.066 | 0.173 | HCV NS5B polymerase inhibitor | 0.173 0.004 DBMET00677 | DBMET00677 | |
| 0.018 | 0.107 | 0.146 | RNA-directed RNA polymerase inhibitor | 0.146 0.004 DBMET00677 | DBMET00677 | |
| 0.029 | 0.133 | 0.052 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.052 0.049 DBMET00677 | DBMET00677 | |
| 0.06 | 0.177 | 0.14 | Mucolytic | 0.14 0.038 DBMET00677 | DBMET00677 | |
| 0.048 | 0.201 | 0.111 | Anabolic | 0.111 0.049 DBMET00677 | DBMET00677 | |
| 0.028 | 0.2 | 0.127 | Antiviral (Hepatitis D) | 0.127 0.004 DBMET00677 | DBMET00677 | |
| 0.054 | 0.242 | 0.191 | Psychostimulant | 0.191 0.085 DBMET00677 | DBMET00677 | |
| 0.014 | 0.229 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET00677 | DBMET00677 | |
| 0.039 | 0.266 | 0.155 | Phosphodiesterase I inhibitor | 0.155 0.016 DBMET00677 | DBMET00677 | |
| 0.006 | 0.269 | 0.044 | Geranyltranstransferase inhibitor | 0.044 0.031 DBMET00677 | DBMET00677 | |
| 0.006 | 0.416 | 0.043 | Purinergic P2X3 antagonist | 0.043 0.015 DBMET00677 | DBMET00677 | |
| 0.024 | 0.46 | 0.361 | Pyruvate kinase inhibitor | 0.361 0.03 DBMET00677 | DBMET00677 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |